Osteomyelitis and Necrotic Bone Complications

Osteomyelitis of the jaws is inflammation of the medullary and cortical bone, most often from a spreading odontogenic infection, that can become chronic and produce dead bone (sequestrum) within reactive new bone (involucrum). Alongside classical infective osteomyelitis, the jaws are subject to necrotic-bone conditions that are not primarily infective in origin - osteoradionecrosis after head-and-neck irradiation and medication-related osteonecrosis after antiresorptive or antiangiogenic therapy - which this topic distinguishes from one another.

Definition

Osteomyelitis of the jaw is an inflammatory, usually infective, process of the jawbone marrow and cortex that may form sequestra and become chronic; necrotic bone complications (osteoradionecrosis, medication-related osteonecrosis) are exposed, non-vital bone arising chiefly from impaired bone vascularity or turnover rather than from primary infection.

Scope

The topic covers infective osteomyelitis of the jaws (acute and chronic) and the principal necrotic-bone complications: osteoradionecrosis and medication-related osteonecrosis of the jaw. It describes pathophysiology and classification and does not give staging-based treatment, hyperbaric oxygen, or surgical recommendations for individuals.

Core questions

• How does odontogenic infection lead to osteomyelitis of the jaw?
• What distinguishes acute from chronic and suppurative from sclerosing osteomyelitis?
• How do osteoradionecrosis and medication-related osteonecrosis differ from infective osteomyelitis?
• What is the role of sequestrum and involucrum in chronic jaw osteomyelitis?

Key concepts

• Acute versus chronic osteomyelitis
• Suppurative versus sclerosing osteomyelitis
• Sequestrum and involucrum
• Medullary bone infection and ischemia
• Osteoradionecrosis
• Medication-related osteonecrosis of the jaw (MRONJ)
• Hypovascular-hypocellular-hypoxic tissue

Mechanisms

Infective osteomyelitis usually begins when odontogenic infection enters the medullary spaces; inflammatory exudate raises intramedullary pressure, compresses and thromboses vessels, and renders segments of bone ischemic and necrotic. Necrotic bone separates as a sequestrum, while the periosteum lays down reactive new bone (involucrum), and the process may persist as chronic suppurative or, with dense bony reaction, sclerosing osteomyelitis (Baltensperger & Eyrich, 2009). Osteoradionecrosis follows a different route: irradiation produces hypovascular, hypocellular, hypoxic bone that fails to maintain or repair itself, so that minor trauma can expose non-healing bone, a model articulated by Marx (1983). Medication-related osteonecrosis of the jaw is associated with antiresorptive (bisphosphonate, denosumab) and antiangiogenic agents that suppress bone turnover and blood supply, leading to exposed, non-vital jawbone that may become secondarily infected (Ruggiero, 2022).

Clinical relevance

These bone conditions sit at the interface of dentistry, oncology, and infectious disease, and distinguishing infective osteomyelitis from radiation- or medication-induced necrosis is fundamental to interpreting the literature on jaw bone disease. The entry is a descriptive reference on pathophysiology and classification; it does not provide staging-based or individualized management.

Epidemiology

Acute infective osteomyelitis of the jaws has become uncommon where dental care and antibiotics are accessible, and it affects the mandible far more than the maxilla because of the mandible's denser, less vascular bone. Osteoradionecrosis occurs in a minority of patients after head-and-neck radiotherapy, with risk related to dose and to dental status, while medication-related osteonecrosis is comparatively rare overall but more frequent in oncology patients on high-dose intravenous antiresorptives than in those on lower-dose therapy for osteoporosis (Ruggiero, 2022).

History

Jaw osteomyelitis was a feared, often disfiguring complication of dental infection in the pre-antibiotic era, and its classification into acute, chronic suppurative, and sclerosing forms matured through the twentieth century. Marx's 1983 reconceptualization of osteoradionecrosis as a hypovascular-hypocellular-hypoxic tissue problem, rather than a simple infection of irradiated bone, reframed that condition. The recognition in the 2000s of osteonecrosis associated with antiresorptive and antiangiogenic drugs added a distinct, medication-related category, codified in successive position papers.

Debates

Is osteoradionecrosis primarily an infection or a vascular-tissue failure?

Marx's hypovascular-hypocellular-hypoxic model recast osteoradionecrosis as a problem of irradiated, poorly perfused bone rather than a primary infection of bone, a reframing that shaped how the condition is conceptualized and debated.

Key figures

• Robert E. Marx
• Salvatore L. Ruggiero
• Marc M. Baltensperger

Seminal works

• marx-1983
• ruggiero-2022
• baltensperger-2009

Frequently asked questions

Why does jaw osteomyelitis affect the mandible more than the maxilla?

The mandible has denser, more compact bone with a relatively limited blood supply, so infection and the resulting ischemia are more readily established and sustained there than in the better-vascularized maxilla.

How is medication-related osteonecrosis of the jaw different from infective osteomyelitis?

Medication-related osteonecrosis is exposed, non-vital jawbone associated with antiresorptive or antiangiogenic drugs that suppress bone turnover and vascularity; infection may be secondary, whereas classical osteomyelitis is a primarily infective inflammation of the bone.